OLIPASS CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 500 KRW | +4.17% |
|
+3.95% | -35.40% |
| 03-18 | OLIPASS Corporation announced that it has received KRW 3.5 billion in funding | CI |
| 03-06 | OLIPASS Corporation announced that it expects to receive KRW 5 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 12.58M | - | - | - | - | - | |
| 124B | ||||||
| 112B | ||||||
| 22.94B | - | |||||
| 22.22B | - | |||||
| 17.02B | - |
